Michael R. Harrison

11.8k citations
176 papers · 6.1k · 3 hit papers · h-index 37

Impact in

    • Cerebrovascular and Carotid Artery Diseases
    • Renal cell carcinoma treatment
    • Prostate Cancer Treatment and Research
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Renal cell carcinoma treatment 50
    • Prostate Cancer Treatment and Research 40
    • Cerebrovascular and Carotid Artery Diseases 16
    • Prostate Cancer Diagnosis and Treatment 16
    • Cancer Immunotherapy and Biomarkers 40

Michael R. Harrison

171 papers receiving 6.0k citations

Michael R. Harrison's Hit Papers

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial 2021 · 175 citations
1750+5+10Years since publication250500750

Peers

Michael R. Harrison
Comparison fields: 5 of 143
  • Pulmonary and Respiratory Medicine 2.9k
  • Oncology 1.8k
  • Cardiology and Cardiovascular Medicine 965
  • Cancer Research 611
  • Surgery 1.7k
Replace Mark W. Onaitis with:
Mark W. Onaitis United States
Akitaka Nonomura Japan
Iris Baumgärtner Switzerland
Richard J. Powell United States
Kazuo Kubota Japan
Cristiana Forni Italy
Louis M. Messina United States
William F. Sindelar United States
Peter Chang United States
Rajiv M. Patel United States
Michael R. Harrison relative to Mark W. Onaitis United States Mark W. Onaitis's profile →
Citations per field
00.5×1.5×2.0×
Mark W. Onaitis · 1×
Citations per year

Countries citing papers authored by Michael R. Harrison

Since Specialization
Citations

This map shows the geographic impact of Michael R. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Harrison more than expected).

Fields of papers citing papers by Michael R. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Harrison. The network helps show where Michael R. Harrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael R. Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael R. Harrison Line = papers co-authored together Michael R. Harrison links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Hit paper breakdown →
2014865
2
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
Hit paper breakdown →
2010580
3 1994236
4 2016187
5 1991184
6 1994181
7 1986180
8
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Hit paper breakdown →
2021175
9 1989167
10 1991154
11 2000140
12 1991134
13 1994126
14 202193
15 201092
16 199990
17 202285
18 202082
19 201382
20 199074

About Michael R. Harrison

Michael R. Harrison is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 176 papers that have together received 6.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (50 papers), Cancer Immunotherapy and Biomarkers (40 papers), Prostate Cancer Treatment and Research (40 papers), Bladder and Urothelial Cancer Treatments (28 papers), Cancer Genomics and Diagnostics (16 papers), Cerebrovascular and Carotid Artery Diseases (16 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Radiopharmaceutical Chemistry and Applications (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.9k citations), Oncology (1.8k citations), Cardiology and Cardiovascular Medicine (965 citations), Cancer Research (611 citations) and Surgery (1.7k citations). Michael R. Harrison has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include N. Scott Adzick, Alan W. Flake, Andrew J. Armstrong, Daniel J. George, Hans J. Hammers, John Marshall, Brian I. Rini, David F. McDermott, Robert J. Motzer and Saby George. Their work appears in journals such as Journal of Clinical Oncology, Prostate Cancer and Prostatic Diseases, Clinical Genitourinary Cancer, Plastic & Reconstructive Surgery and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact